SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Colinz Laboratories - Quaterly Results

16 May 2025 Evaluate
Net sales declined -10.93%  to  Rs. 14.51 million from Rs. 16.29 millions.Net profit stood at Rs. 1.50  millions  compared to Rs. 1.34 millions in the corresponding previous quarter,high by 11.94%.Operating profit for the quarter ended March 2025 decreased to 1.74 millions as compared to 2.31 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 14.51 16.29 -10.93 65.28 70.30 -7.14 65.28 70.30 -7.14
Other Income 0.76 1.07 -28.97 2.98 2.75 8.36 2.98 2.75 8.36
PBIDT 1.74 2.31 -24.68 7.94 8.17 -2.82 7.94 8.17 -2.82
Interest 0.16 0.10 60.00 0.42 0.37 13.51 0.42 0.37 13.51
PBDT 1.58 2.21 -28.51 7.52 7.80 -3.59 7.52 7.80 -3.59
Depreciation 0.35 0.33 6.06 1.31 1.30 0.77 1.31 1.30 0.77
PBT 1.23 1.88 -34.57 6.21 6.50 -4.46 6.21 6.50 -4.46
TAX -0.27 0.54 -150.00 1.23 1.64 -25.00 1.23 1.64 -25.00
Deferred Tax -0.52 -0.02 2500.00 -0.52 -0.02 2500.00 -0.52 -0.02 2500.00
PAT 1.50 1.34 11.94 4.98 4.86 2.47 4.98 4.86 2.47
Equity 25.19 25.19 0.00 25.19 25.19 0.00 25.19 25.19 0.00
PBIDTM(%) 11.99 14.18 -15.44 12.16 11.62 4.66 12.16 11.62 4.66

Colinz Laboratories Share Price

53.15 -2.75 (-4.92%)
11-Jun-2026 14:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1789.35
Dr. Reddys Lab 1274.15
Cipla 1384.95
Zydus Lifesciences 1105.00
Lupin 2276.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: